S100A8 and chronic myelogenous leukemia, BCR-ABL1 positive: Although CML levels are elevated in diabetic patients, the relative contribution of other RAGE ligands, such as high mobility group box 1 (HMGB1) and S100A8/A9, may also be essential factors [50].